| Health effects of black carbon NAH Janssen, ME Gerlofs-Nijland, T Lanki, RO Salonen, F Cassee, ... World Health Organization. Regional Office for Europe, 2012 | 601 | 2012 |
| Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage M Merker, C Blin, S Mona, N Duforet-Frebourg, S Lecher, E Willery, ... Nature genetics 47 (3), 242-249, 2015 | 532 | 2015 |
| Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement C Lange, I Abubakar, JWC Alffenaar, G Bothamley, JA Caminero, ... European Respiratory Journal 44 (1), 23-63, 2014 | 389 | 2014 |
| Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages D Stucki, D Brites, L Jeljeli, M Coscolla, Q Liu, A Trauner, L Fenner, ... Nature genetics 48 (12), 1535-1543, 2016 | 313 | 2016 |
| Building a tuberculosis-free world: The Lancet Commission on tuberculosis MJA Reid, N Arinaminpathy, A Bloom, BR Bloom, C Boehme, R Chaisson, ... The Lancet 393 (10178), 1331-1384, 2019 | 280 | 2019 |
| Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance AL Manson, KA Cohen, T Abeel, CA Desjardins, DT Armstrong, ... Nature genetics 49 (3), 395-402, 2017 | 251 | 2017 |
| Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations TC Rodwell, F Valafar, J Douglas, L Qian, RS Garfein, A Chawla, J Torres, ... Journal of clinical microbiology 52 (3), 781-789, 2014 | 154 | 2014 |
| First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistances V Crudu, E Stratan, E Romancenco, V Allerheiligen, A Hillemann, ... Journal of clinical microbiology 50 (4), 1264-1269, 2012 | 129 | 2012 |
| Multidrug-resistant tuberculosis in Europe, 2010–2011 G Günther, F Van Leth, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... Emerging infectious diseases 21 (3), 409, 2015 | 118 | 2015 |
| Beyond the SNP threshold: identifying outbreak clusters using inferred transmissions J Stimson, J Gardy, B Mathema, V Crudu, T Cohen, C Colijn Molecular biology and evolution 36 (3), 587-603, 2019 | 113 | 2019 |
| Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates JN Torres, LV Paul, TC Rodwell, TC Victor, AM Amallraja, A Elghraoui, ... Emerging microbes & infections 4 (1), 1-9, 2015 | 110 | 2015 |
| Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country HE Jenkins, V Plesca, A Ciobanu, V Crudu, I Galusca, V Soltan, ... European Respiratory Journal 42 (5), 1291-1301, 2013 | 93 | 2013 |
| Detection of low-level mixed-population drug resistance in Mycobacterium tuberculosis using high fidelity amplicon sequencing RE Colman, JM Schupp, ND Hicks, DE Smith, JL Buchhagen, F Valafar, ... PloS one 10 (5), e0126626, 2015 | 92 | 2015 |
| Rapid drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates directly from clinical samples by use of amplicon sequencing: a proof-of-concept study RE Colman, J Anderson, D Lemmer, E Lehmkuhl, SB Georghiou, ... Journal of clinical microbiology 54 (8), 2058-2067, 2016 | 90 | 2016 |
| The TB portals: an open-access, web-based platform for global drug-resistant-tuberculosis data sharing and analysis A Rosenthal, A Gabrielian, E Engle, DE Hurt, S Alexandru, V Crudu, ... Journal of clinical microbiology 55 (11), 3267-3282, 2017 | 83 | 2017 |
| Treatment outcomes in multidrug-resistant tuberculosis G Guenther, C Lange, S Alexandru, N Altet, K Avsar, D Bang, R Barbuta, ... N Engl J Med 375, 1103-1105, 2016 | 82 | 2016 |
| Armed conflict and population displacement as drivers of the evolution and dispersal of Mycobacterium tuberculosis V Eldholm, JHO Pettersson, OB Brynildsrud, A Kitchen, EM Rasmussen, ... Proceedings of the National Academy of Sciences 113 (48), 13881-13886, 2016 | 74 | 2016 |
| Assessing tuberculosis control priorities in high-burden settings: a modelling approach JF Vesga, TB Hallett, MJA Reid, KS Sachdeva, R Rao, S Khaparde, ... The Lancet Global Health 7 (5), e585-e595, 2019 | 67 | 2019 |
| Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova HE Jenkins, A Ciobanu, V Plesca, V Crudu, I Galusca, V Soltan, T Cohen The International journal of tuberculosis and lung disease 17 (3), 373-380, 2013 | 58 | 2013 |
| Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries K Ajbani, SYG Lin, C Rodrigues, D Nguyen, F Arroyo, J Kaping, L Jackson, ... Antimicrobial agents and chemotherapy 59 (1), 414-420, 2015 | 52 | 2015 |
Donald CatanzaroResearch Assistant Professor of Biological Sciences, University of ArkansasVerified email at uark.edu
